期刊文献+

抗病毒治疗的HIV/AIDS病人生存状况的影响因素 被引量:3

Review of the survival analysis of HIV/AIDS patients receiving highly active antiretroviral therapy
原文传递
导出
摘要 随着艾滋病(AIDS)高效抗反转录病毒治疗(HAART)时间的积累,艾滋病病毒(HIV)感染者/AIDS病人(简称HIV/AIDS病人)生存状况及影响因素分析,成为近年来国内外艾滋病研究领域关注的热点和重点。研究常用回顾性队列研究方法,采用寿命表法计算生存率,并绘制相关影响因子的Kaplan-Meier生存曲线。Cox比例风险回归模型单因素和多因素分析显示,年龄、性别、婚姻状况、BMI指数、感染途径、世界卫生组织的临床分期、基线CD4+T淋巴细胞水平等,是影响艾滋病抗病毒治疗生存时间的危险因素。针对重点人群加大艾滋病抗病毒治疗的宣传力度,早发现早诊断早治疗,提高治疗覆盖率,可以有效保障治疗效果,延长病人生存时间。 Along with the progress of highly active antiretroviral therapy (HAART) for HIV/AIDS patients, more and more researches highlight the elements impacting on mortality and survival condition. Retrospective cohort studies are usually conducted with survival rate calculated through life table and different influence factors described by Kaplan-Meier curves. Bivariate and multivariable Cox proportional hazards regression models show that age, sex, marital status, BMI, route of transmission, clinical stages, baseline CD4 count are usually identified as the independent predictors of mortality. We should enhance the awareness of HAART targeting people living with HIV/ AIDS. The strategy of early detection, early diagnosis and early treatment is helpful to increase treatment coverage, which can effectively guarantee treatment effect and prolong survival time of HIV/AIDS patients.
出处 《中国艾滋病性病》 CAS 北大核心 2016年第9期759-762,共4页 Chinese Journal of Aids & STD
关键词 艾滋病病毒感染者/艾滋病病人 高效抗反转录病毒治疗 生存时间 影响因素 HIV/AIDS patients HAART Survival time Influence factors
  • 相关文献

参考文献7

二级参考文献54

  • 1张福杰,文毅,于兰,马烨,潘捷,赵燕.艾滋病的抗病毒治疗与我国的免费治疗现状[J].科技导报,2005,23(7):24-29. 被引量:106
  • 2张福杰,曹韵贞,赵红心,等.国家免费艾滋病抗病毒药物治疗手册.2版.北京:人民卫生出版社,2008.
  • 3Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med, 1998,338:853-860.
  • 4Zhang F, Dou Z, Ma Y, et al. Five-Year Outcomes of the China national Free Antiretroviral Treatment Program. Ann Intern Med, 2009,151 : 242 -251.
  • 5Palella FJ Jr, Baker RK, Moorman AC, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr,2006,43:27-34.
  • 6Murphy EL, Collier AC, Kalish LA, et al. Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med,2001,135 :17-26.
  • 7Stringer JS, Zulu I, Levy J, et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA, 2006,296 : 782 -793.
  • 8Zhang F, Dou Z, Yu L, et al. The Effect of Highly Active Antiretroviral Therapy on Mortality in HIV-Infected Former Plasma Donors in China. Clin Infect Dis ,2008,47:825-833.
  • 9Jelsma J, Maclean E, Hughes J, et al. An investigation into the re- lated quality of life of individuals living with HIV who are receiv- ing HAART [ J ]. AIDS Care,2005,17 (5) :555 - 579.
  • 10张富杰.国家免费艾滋病抗病毒药物治疗手册[M].2版.人民卫生出版社,2008.

共引文献241

同被引文献26

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部